Gene Query: DHX38

Dataset Description Geneva Score
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 36.65
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 21.69
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 21.69
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 21.43
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 16.17
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 15.96
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 14.52
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 14.5
RNA-Seq analysis of breast cancer cells after shikonin treatment 14.2
RNA transcriptome analysis during HSV-1 infection 13.74
Transcriptomic analysis of LSD1 13.51
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 13.38
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 12.96
The regulartory role of ZCCHC24 in splicing machinery 12.93
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 12.89
Genome wide miR-191 target profile determined by RIP and gene expression profiling 12.4
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 12.4
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 12.0
Intrahepatic MAIT cell gene expression revealed by RNA-seq 11.59
MOF acetyl transferase regulates transcription and respiration in mitochondria 11.56
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 11.33
Gene expression alterations associated with acquired-resistance to the CDK4/6 inhibitor palbociclib [Palbociclib resistance_RNASeq] 11.12
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 10.92
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 10.57
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 10.55
Genome wide expression change by RNF168 knocking down in NEC cells 10.29
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 10.26
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 10.26
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 9.91
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 9.91
Global transcriptome analysis of HAP1 cells 9.72
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 9.56
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 9.56
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 9.55
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 9.52
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 9.5
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 9.5
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 9.49
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 9.49
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 9.46
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 9.46
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 9.46
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 9.45
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 9.23
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 9.23
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 9.2
Expression level comparison under dividing and quiescent states in human primary fibroblasts 9.18
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 8.97
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 8.96
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 8.92
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 8.92
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 8.9
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 8.86
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 8.81
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 8.75
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 8.72
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 8.66
Searching for target genes of miR-508/509/506/514 in HCT116 cells 8.58
Mechanistic Model-Guided Study of Embryonic Morphogenesis 8.58
High-throughput sequencing of pluripotent cells 8.49
AUF-1 affected genes in human skin cells 8.46
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 8.41
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 8.41
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 8.28
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 8.24
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 8.12
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 8.11
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 8.03
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 8.03
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 7.74
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 7.74
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 7.57
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 7.56
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 7.48
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 7.48
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 7.47
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 7.47
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 7.44
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 7.44
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 7.42
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 7.38
Differentially expressed genes post knock down of lincDUSP26 7.35
Landscape and variation of RNA secondary structure across the human transcriptome 7.35
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 7.28
Effect of mitochondria deficiency on senescence-associated gene expression 7.21
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 7.08
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 7.07
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 7.05
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 7.03
R430: A potent inbibitor of DNA and RNA viruses 6.95
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 6.89
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 6.89
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 6.89
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 6.84
RNA sequencing of primary human platelets and in vitro cell lines 6.75
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 6.72
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 6.71
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 6.71
DART-seq: an antibody-free method for global m6A detection 6.7
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 6.68
Combined Genome and Transcriptome Sequencing to Identify Allelic Selection in Epithelial Ovarian Cancer 6.67
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 6.67
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 6.62
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 6.6
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 6.58
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 6.56
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 6.53
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 6.51
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 6.49
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 6.47
Disruption of the exocyst induces podocyte loss and dysfunction 6.46
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 6.46
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 6.44
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 6.38
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 6.32
Global gene expression profile of dasatinib-resistant RCH-ACV cells 6.32
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 6.3
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 6.27
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 6.27
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 6.27
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 6.26
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 6.25
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 6.24
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 6.17
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 6.1
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 6.08
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 6.05
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 6.05
mRNA expression profile of Lymphocytes by high-throuput sequencing 6.01
RNA-seq analysis of BAP1-depleted uveal melanoma cells 6.0
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 5.99
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 5.98
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 5.98
MicroRNA targetome analysis during HCMV infection 5.95
A TGFbeta-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression 5.91
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 5.89
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 5.89
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 5.89
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 5.88
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 5.88
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 5.83
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 5.83
METTL3 promotes translation in human cancer cells 5.81
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 5.78
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 5.78
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 5.78
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 5.75
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 5.75
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 5.75
TCF7L1 knockdown in pancreatic cancer 5.72
miR941 overexpression experiment 5.72
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 5.71
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 5.7
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 5.69
RNA-seq analysis of melanoma and carcinoma cells expressing FOXQ1 5.66
RNA seq comparison between scrambled and shGRP78 cells 5.66
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 5.66
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 5.66
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 5.62
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 5.52
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 5.5
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 5.48
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 5.47
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 5.45
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 5.44
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 5.42
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 5.42
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 5.42
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 5.41
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 5.41
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 5.4
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 5.36
Role of XRN2 ribonucleolytic activity in RNA metabolism 5.33
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 5.32
Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation 5.18
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 5.18
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 5.17
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 5.16
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 5.12
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 5.1
SRSF1 role in cellular gene expression and splicing 5.09
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 5.08
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 5.07
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 5.05
Genetic-to-epigenetic Therapy for Pancreatic Cancer 5.05
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 5.03
RNA-sequencing in irradiated and normal A549 cells. 5.02
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 5.01
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 5.01
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 5.01
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 4.99
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 4.97
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 4.94
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 4.93
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 4.93
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites 4.91
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites (RNA-seq) 4.91
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 4.9
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 4.9
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 4.85
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 4.85
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 4.84
NKX2.2 4.83
RNA-Seq analysis of NKX2.2 knockdown in human pancreatic islets 4.83
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 4.81
4.78
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 4.76
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 4.75
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 4.75
Studying the selectivity of a small molecule Synucleozid on transcriptome 4.69
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 4.66
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 4.66
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 4.59
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 4.59
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 4.51
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 4.5
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 4.49
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 4.46
The DPYSL2 gene connects mTOR and schizophrenia 4.45
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 4.41
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 4.38
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 4.38
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 4.36
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 4.32
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 4.23
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 4.17
Chromatin landscape of human visceral and subcutaneous adipocytes 4.15
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 4.15
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 4.14
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 4.13
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 4.12
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 4.12
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 4.04
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 3.99
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 3.99
Hepatitis C virus functionally sequesters miR-122 3.99
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 3.98
TCF21 and Aryl-hydrocarbon receptor gene cooperate to activate a pro-atherosclerotic gene expression program 3.98
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 3.95
HBEC-shp53-PCHD7 3.94
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 3.94
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 3.94
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 3.88
Cajal bodies are linked to genome conformation 3.83
Cajal bodies are linked to genome conformation [RNA-Seq] 3.83
Global gene expression profiles of cardiac progenitors differentiated from human pluripotent stem cells in 3D culture under simulated microgravity 3.82
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 3.8
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 3.76
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 3.76
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 3.74
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 3.73
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 3.73
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 3.71
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 3.69
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 3.66
FBXW7 modulates stress response by post-translational modification of HSF1 3.66
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 3.66
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 3.63
miRNAs affected by antagomiR-17 treatment 3.61
METTL3 and WTAP 3.59
RNA splicing alteration on glioblastoma and normal neural stem cells 3.54
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 3.52
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 3.47
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 3.46
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 3.39
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 3.36
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 3.29
RNA-seq of RKO cells with cTAZ KO or putback 3.26
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 3.26
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 3.23
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 3.19
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 3.19
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 3.17
Effect of from Human Umbilical Vein Endothelial Cells 3.16
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 3.14
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 3.14
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 3.09
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 3.09
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 3.08
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 3.08
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.06
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 3.05
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 3.02
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 3.0
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 2.98
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 2.98
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 2.96
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 2.95
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 2.92
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 2.91
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 2.88
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 2.86
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 2.84
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 2.84
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 2.83
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 2.78
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 2.77
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 2.76
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 2.76
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 2.74
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 2.7
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 2.67
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 2.66
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 2.65
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 2.63
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 2.63
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  2.62
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 2.59
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 2.59
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 2.55
Epigenetic reprogramming of melanoma cells by vitamin C treatment 2.55
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 2.55
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 2.54
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 2.54
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 2.54
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 2.54
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 2.53
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 2.49
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 2.49
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 2.48
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 2.48
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 2.47
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 2.44
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 2.43
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 2.38
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 2.38
Transcriptome landscape of HeLa response upon triamcinolone acetonide 2.38
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 2.37
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 2.36
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 2.35
Defective structural RNA processing in relapsing-remitting multiple sclerosis 2.34
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 2.32
RNA seq_PDX2_SHP099 2.32
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure by siRNA knockdown of Anillin [tpo8] 2.31
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 2.25
X-Ray induced DNA-Hydroxymethylation changes 2.25
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 2.21
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 2.21
Solid phase chemistry to covalently and reversibly capture thiolated RNA 2.18
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 2.12
miR-93 Targets in Human Endothelial Cells 2.1
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 2.08
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 2.06
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 2.05
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 2.01
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 2.01
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 2.01
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 2.0
A novel target of EZH1/2 for treatment of mantle cell lymphoma 1.97
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 1.96
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 1.94
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 1.93
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 1.93
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 1.91
ETV7 and interferon response 1.9
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 1.9
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 1.9
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 1.9
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 1.89
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 1.89
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 1.89
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 1.87
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 1.83
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 1.82
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.8
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 1.78
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 1.74
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 1.7
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 1.7
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 1.68
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 1.68
CDK12 mediated transcriptional regulation in U2OS cells 1.67
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 1.65
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 1.63
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 1.62
Energy Metabolism during Anchorage-Independence 1.62
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 1.59
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 1.59
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 1.59
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 1.58
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 1.58
Effect of ILF3 on translation during homeostasis and the antiviral response 1.54
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HCT116 cells treated with or without TNF-alpha 1.51
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 1.5
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 1.48
IMP3 regulated gene expression in breast cancer cells 1.45
Modeling Human Cancer-induced Cachexia (Human) 1.43
Metabolism as an early predictor of DPSCs aging 1.43
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 1.39
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 1.39
RNA-seq of CD33 KO and control HSPCs 1.36
Transcriptome profiling of A2M treated A549 Cell Line Samples 1.36
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 1.34
Patient-derived xenograft platform for metastatic melanoma 1.32
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 1.3
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 1.28
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 1.28
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 1.28
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 1.27
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 1.23
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 1.19
Transcriptome analysis upon C6orf203 silencing 1.19
Glucose inhibits cardiac maturation through nucleotide biosynthesis 1.18
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 1.16
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 1.16
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 1.15
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 1.13
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 1.12
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 1.11
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 1.1
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 1.09
Single-cell analysis of human kidney organoids 1.07
siRNA-mediated knockdown 1.07
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 0.99
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 0.99
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.98
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 0.96
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.94
Expression profiling of MCF-7 cells with treatment of TCDD 0.91
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 0.91
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 0.89
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 0.89
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 0.89
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 0.87
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.86
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 0.85
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 0.85
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 0.83
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 0.81
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 0.81
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 0.8
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 0.8
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 0.79
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 0.78
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 0.76
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.76
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 0.75
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 0.75
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.74
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.74
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 0.7
The control of rRNA synthesis during the directed differentiation of human embryonic stem cells precedes heterochromatin formation. 0.69
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 0.66
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 0.66
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 0.66
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 0.62
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 0.62
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 0.62
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 0.61
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 0.6
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 0.59
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.57
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.55
Illumina Total RNA-seq in HeLa 0.53
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 0.52
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.52
Folate modulation induces chromosomal instability and higher proliferation of immortalized human keratinocytes 0.47
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 0.47
Effect of BB608 on Gene Expression in HNSCC Cell Line 0.45
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 0.44
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 0.41
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 0.4
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 0.39
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 0.39
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 0.39
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.37
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.37
Global transcriptome analysis of WT versus HEB-/- hESCs 0.36
Transposon-based construction of strand-specific RNA-seq libraries 0.36
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 0.34
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 0.32
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 0.31
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.28
Downregulation of LATS kinases alters p53 to promote cell migration 0.24
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.21
The role of m6A/m-RNA methylation in stress response regulation 0.21
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 0.2
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.17
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.17
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.17
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.17
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 0.16
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 0.15
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.14
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.14
The pioneer factor CEBPA modulates vitamin D signaling 0.14
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 0.14
Regulation of hypoxia-inducible factor activity by ZMYND8 0.12
A novel non-canonical signaling pathway mediates TGF-β1-induced glucocorticoid insensitivity in epithelial cells 0.11
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 0.11
Myc activation coordinates gene transcription and protein translation responses 0.07
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.05
Determining mRNA half-lives on a transcriptome-wide scale 0.05
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 0.04
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 0.02
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 0.02
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.0
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.0
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.0
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation